CCN1 is critical for acid-induced esophageal epithelial cell transformation

Biochemical and Biophysical Research Communications

Volumn 392, Issue 4, 2010, Pages 533-537

  Modak, Cristina ^a   Mouazzen, Wasim ^a   Narvaez, Reinier ^a   Reavis, Kevin M ^a,b   Chai, Jianyuan ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CCN1; EAC; EMT; GERD

Indexed keywords

COMPLEMENTARY DNA; CYSTEINE RICH PROTEIN 61; UVOMORULIN;

ARTICLE; CELL JUNCTION; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MALIGNANT TRANSFORMATION; MESENCHYME CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH ACID; WESTERN BLOTTING;

ADENOCARCINOMA; ADHERENS JUNCTIONS; CADHERINS; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE-RICH PROTEIN 61; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYDROGEN-ION CONCENTRATION; MESODERM; RNA INTERFERENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 76749103238     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.057     Document Type: Article

References (31)

1. Trivers K.F., Sabatino S.A., and Stewart S.L. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int. J. Cancer 123 (2008) 1422-1428
2. Jemal A., Thun M.J., Ries L.A., Howe H.L., Weir H.K., Center M.M., Ward E., Wu X.C., Eheman C., Anderson R., Ajani U.A., Kohler B., and Edwards B.K. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use and tobacco control. J. Natl. Cancer Inst. 100 (2008) 1672-1694
3. Goldstein S.R., Yang G., Curtis S.K., Reuhl K.R., Liu B.C., Mirvish S.S., Newmark H.L., and Yang C.S. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 18 (1997) 2265-2270
4. Di Martino E., Wild C.P., Rotimi O., Darnton S.J., Olliver J.R., and Hardie L.J. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk. Biomarkers 11 (2006) 547-561
5. Duggan S.P., Gallagher W.M., Fox E.J.P., Abdel-Latif M.M., Reynolds J.V., and Kelleher D. Low pH induces co-ordinate regulation of gene expression in oesophageal cells. Carcinogenesis 27 (2006) 319-327
6. McManus D.T., Olaru A., and Meltzer S.J. Biomarkers of esophageal adenocaricnoma and Barrett's esophagus. Cancer Res. 64 (2004) 1561-1569
7. Lao-Sirieix P., Roy A., Worrall C., Vowler S.L., Gardiner S., and Fitzgerald R.C. Effect of acid suppression on molecular predictors for esophageal cancer. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 288-293
8. Lau L.F., and Nathans D. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J. 4 (1985) 3145-3151
9. O'Brien T.P., Yang G.P., Sanders L., and Lau L.F. Expression of Cyr61, a growth factor-inducible immediate-early gene. Mol. Cell Biol. 10 (1990) 3569-3577
10. Brigstock D.R. The CCN family: a new stimulus package. J. Endocrinol. 178 (2003) 169-175
11. Perbal B. CCN proteins: multifunctionl signaling regulators. Lancet 363 (2004) 62-64
12. Leask A., and Abraham D.J. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 119 (2006) 4803-4810
13. Chen Y., and Du X.Y. Functional properties and intracellular signaling of CCN1/Cyr61. J. Cell. Biochem. 100 (2007) 1337-1345
14. Kireeva M.L., Mo F.E., Yang G.P., and Lau L.F. Cyr61, a product of growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol. Cell Biol. 16 (1996) 1326-1334
15. Chen C.C., Chen N., and Lau L.F. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J. Biol. Chem. 276 (2001) 10443-10452
16. Chen C.C., Mo F.E., and Lau L.F. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J. Biol. Chem. 276 (2001) 47329-47337
17. Lin M.T., Chang C.C., Chen S.T., Chang H.L., Su J.L., Chau Y.P., and Kuo M.L. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. J. Biol. Chem. 279 (2004) 24015-24023
18. Xie D., Yin D., Tong X., O'Kelly J., Mori A., Miller C., Black K., Gui D., Said J.W., and Koeffler H.P. Cyr61 is over-expressed in gliomas and involved in integrin-linked kinse-mediated Akt and β-catenin-TCF/Lef signaling pathways. Cancer Res. 64 (2004) 1987-1996
19. Washington K., Chiappori A., Hamilton K., Shyr Y., Blanke C., Johnson D., Sawyers J., and Beauchamp D. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Mod. Pathol. 11 (1998) 805-813
20. Bailey T., Biddlestone L., Shepherd N., Barr H., Warner P., and Jankowski J. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am. J. Pathol. 152 (1998) 135-144
21. Gloushankova N.A. Changes in regulation of cell-cell adhesion during tumor transformation. Biochemistry (Moscow) 73 (2008) 925-934
22. Natalwala A., Spychal R., and Tselepis C. Epithelial-mesenchymal transition mediates tumorigenesis in the gastrointestinal tract. World J. Gastroenterol. 14 (2008) 3792-3797
23. Bian Y.S., Osterheld M.C., Bosman F.T., Fontolliet C., and Benhattar J. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus. Am. J. Clin. Pathol. 114 (2000) 583-590
24. Lin S.Y., Xia W., Wang J.C., Kwong K.Y., Spohn B., Wen Y., Pestell R.G., and Hung M.C. β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. 97 (2000) 4262-4266
25. Kolligs F.T., Bommer G., and Goeke B. Wnt/beta-catenin/Tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66 (2002) 131-144
26. Osterheld M.C., Bian Y.S., Bosman F.T., Benhatter J., and Fontolliet C. Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. Am. J. Clin. Pathol. 117 (2002) 451-456
27. Larue L., and Delmas V. The WNT/beta-catenin pathway in melanoma. Front. Biosci. 11 (2006) 733-742
28. Takemaru K.I., Ohmitsu M., and Li F.Q. An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics. Handb. Exp. Pharmacol. 186 (2008) 261-284
29. Chai J., Norng M., Tarnawski A.S., and Chow J. A critical role of Serum response factor in myofibroblast differentiation during experimental esophageal ulcer healing in rat. Gut 56 (2007) 621-630
30. Chai J., Jones M.K., and Tarnawski A.S. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis: insight into the mechanisms. FASEB J. 18 (2004) 1264-1266
31. Modak C., and Bryant P.J. Casein kinase 1 epsilon positively regulates the Akt pathway in breast cancer cell lines. Biochem. Biophys. Res. Commun. 368 (2008) 801-807